Skip Navigation


BJA Advance Access originally published online on February 18, 2005
British Journal of Anaesthesia 2005 94(5):556-562; doi:10.1093/bja/aei093
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/5/556    most recent
aei093v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Skrabanja, A. T. P.
Right arrow Articles by Dagnelie, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skrabanja, A. T. P.
Right arrow Articles by Dagnelie, P. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journal.permissions{at}oupjournals.org

Potential value of adenosine 5'-triphosphate (ATP) and adenosine in anaesthesia and intensive care medicine

A. T. P. Skrabanja1,*, E. A. C. Bouman2 and P. C. Dagnelie1

1 Department of Epidemiology, NUTRIM, Maastricht University, Maastricht, The Netherlands. 2 Department of Anaesthesiology, University Hospital Maastricht, The Netherlands

* Corresponding author. E-mail: arno.skrabanja{at}epid.unimaas.nl

Extracellular adenosine and adenosine triphosphate (ATP) are involved in biological processes including neurotransmission, muscle contraction, cardiac function, platelet function, vasodilatation, signal transduction and secretion in a variety of cell types. They are released from the cytoplasm of several cell types and interact with specific purinergic receptors which are present on the surface of many cells. This review summarizes the evidence on the potential value and applicability of ATP (not restricted to ATP–MgCl2) and adenosine in the field of anaesthesia and intensive care medicine. It focuses, in particular, on evidence and roles in treatment of acute and chronic pain and in sepsis. Based on the evidence from animal and clinical studies performed during the last 20 years, ATP could provide a valuable addition to the therapeutic options in anaesthesia and intensive care medicine. It may have particular roles in pain management, modulation of haemodynamics and treatment of shock.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
C. Kakazu, M. Lippmann, R. A. White, A. T. P. Skrabanja, E. A. C. Bouman, and P. C. Dagnelie
Additional use for adenosine in anaesthesia and surgery
Br. J. Anaesth., December 1, 2005; 95(6): 836 - 837.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.